{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T21:54:08Z","timestamp":1770155648544,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peripheral blood hematopoietic cell transplantation (PBHCT) is a feasible treatment option for dogs with B-cell lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine apheresis and PBHCT outcomes in dogs diagnosed with T-cell lymphoma (TCL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Fifteen client-owned dogs diagnosed with high-grade TCL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After high-dose cyclophosphamide and rhG-colony-stimulating (rhG-CSF) factor treatment, peripheral blood mononuclear cells were collected using cell separators. The harvested cells then were infused after varying doses of total body irradiation (TBI). Postirradiation adverse effects were managed symptomatically and dogs were discharged upon evidence of hematopoietic engraftment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>More than 2 \u00d7 106 CD34+ cells\/kg were harvested from 15\/15 dogs. Thirteen of 15 (87%) dogs engrafted appropriately, whereas 2 (13%) of the dogs died in the hospital. One dog developed cutaneous B-cell lymphoma 120 days post-PBHCT. The median disease-free interval and overall survival (OS) of the 13 dogs transplanted in first remission from the time of PBHCT were 184 and 240 days, respectively. Stage and substage of disease at diagnosis had no effect on OS. Two of 13 (15%) dogs were alive 741 and 772 days post-PBHCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>PBHCT may be considered as a treatment option for dogs with TCL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.12302","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T12:55:10Z","timestamp":1390827310000},"page":"529-537","source":"Crossref","is-referenced-by-count":28,"title":["Autologous Peripheral Blood Hematopoietic Cell Transplantation in Dogs with T-Cell Lymphoma"],"prefix":"10.1093","volume":"28","author":[{"given":"E.E.","family":"Warry","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University Department of Clinical Sciences, , Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Willcox","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University Department of Clinical Sciences, , Raleigh, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.E.","family":"Suter","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University Department of Clinical Sciences, , Raleigh, NC"},{"name":"Center for Comparative Medicine and Translational Research, North Carolina State University , Raleigh, NC"},{"name":"Lineberger Comprehensive Cancer Center , Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,1]]},"reference":[{"key":"2026020304371686700_jvim12302-bib-0001","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1354\/vp.39-1-92","article-title":"Canine T-cell lymphomas: A morphological, immunological, and clinical study of 46 new cases","volume":"39","author":"Fournel-Fleury","year":"2002","journal-title":"Vet Pathol"},{"key":"2026020304371686700_jvim12302-bib-0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cll.2010.10.001","article-title":"The diagnostic assessment of canine lymphoma: Implications for treatment","volume":"31","author":"Bienzle","year":"2011","journal-title":"Clin Lab Med"},{"key":"2026020304371686700_jvim12302-bib-0003","first-page":"2148","volume-title":"Textbook of Veterinary Internal Medicine","author":"Vail","year":"2010","edition":"7th ed"},{"key":"2026020304371686700_jvim12302-bib-0004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1939-1676.1993.tb01021.x","article-title":"Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma","volume":"7","author":"Keller","year":"1993","journal-title":"J Vet Intern Med"},{"key":"2026020304371686700_jvim12302-bib-0005","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1939-1676.2002.tb02411.x","article-title":"Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma","volume":"16","author":"Garrett","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020304371686700_jvim12302-bib-0006","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1939-1676.2004.tb02609.x","article-title":"Chemotherapy followed by half-body radiation therapy for canine lymphoma","volume":"18","author":"Williams","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020304371686700_jvim12302-bib-0007","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1939-1676.2009.0353.x","article-title":"Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma","volume":"23","author":"Lurie","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020304371686700_jvim12302-bib-0008","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1476-5829.2012.00318.x","article-title":"Diagnostic evaluation and treatment recommendations for dogs with substage-a high-grade multicentric lymphoma: Results of a survey of veterinarians","volume":"11(4)","author":"Regan","year":"2013","journal-title":"Vet Comp Oncol"},{"key":"2026020304371686700_jvim12302-bib-0009","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1939-1676.2007.tb01932.x","article-title":"Treatment of dogs with lymphoma: A work in progress","volume":"21","author":"Legendre","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020304371686700_jvim12302-bib-0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1939-1676.2012.00980.x","article-title":"Autologous peripheral blood hematopoietic cell transplantation in dogs with B-cell lymphoma","volume":"26","author":"Willcox","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020304371686700_jvim12302-bib-0011","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/vaa.12026","article-title":"Apheresis in three dogs weighing &lt;14 kg","volume":"40(4)","author":"Posner","year":"2013","journal-title":"Vet Anaesth Analg"},{"key":"2026020304371686700_jvim12302-bib-0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1354\/vp.40-1-32","article-title":"Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes","volume":"40","author":"Burnett","year":"2003","journal-title":"Vet Pathol"},{"key":"2026020304371686700_jvim12302-bib-0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00007890-197810000-00008","article-title":"Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model","volume":"26","author":"Appelbaum","year":"1976","journal-title":"Transplantation"},{"key":"2026020304371686700_jvim12302-bib-0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2011.00283.x","article-title":"Veterinary cooperative oncology group-common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy of biological antineoplastic therapy in dogs and cats v1.1","volume-title":"Vet Comp Oncol","author":"VCOG","year":"2011"},{"key":"2026020304371686700_jvim12302-bib-0015","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00007890-199112000-00004","article-title":"Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood","volume":"52","author":"Bean","year":"1991","journal-title":"Transplantation"},{"key":"2026020304371686700_jvim12302-bib-0016","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0360-3016(88)90307-0","article-title":"Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: Effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity","volume":"15","author":"Deeg","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026020304371686700_jvim12302-bib-0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0360-3016(02)02743-8","article-title":"Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy","volume":"53","author":"McAfee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026020304371686700_jvim12302-bib-0018","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1200\/JCO.1993.11.6.1062","article-title":"Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease","volume":"11","author":"Yahalom","year":"1993","journal-title":"J Clin Oncol"},{"key":"2026020304371686700_jvim12302-bib-0019","first-page":"167","article-title":"Protective effects of glutamine enriched diets on acute actinic enteritis","volume":"11","author":"Campos","year":"1996","journal-title":"Nutr Hosp"},{"key":"2026020304371686700_jvim12302-bib-0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1701317","article-title":"Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation","volume":"22","author":"Anderson","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2026020304371686700_jvim12302-bib-0021","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bbmt.2008.05.021","article-title":"Second autologous stem cell transplantation for relapsed lymphoma after prior autologous transplant","volume":"14","author":"Smith","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026020304371686700_jvim12302-bib-0022","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00277-011-1227-y","article-title":"Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation","volume":"90","author":"Kim","year":"2011","journal-title":"Ann Hematol"},{"key":"2026020304371686700_jvim12302-bib-0023","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/0360-3016(83)90325-5","article-title":"Increased incidence of malignant tumors in dogs after total body irradiation and marrow tranpslantation","volume":"9","author":"Deeg","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026020304371686700_jvim12302-bib-0024","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1200\/JCO.2005.05.158","article-title":"Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma","volume":"23","author":"Brown","year":"2005","journal-title":"J Clin Oncol"},{"key":"2026020304371686700_jvim12302-bib-0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/1097-0142(19900801)66:3<480::AID-CNCR2820660314>3.0.CO;2-X","article-title":"Lymphoma in dogs: A morphologic, immunologic, and clinical study","volume":"66","author":"Greenlee","year":"1990","journal-title":"Cancer"},{"key":"2026020304371686700_jvim12302-bib-0026","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2460\/javma.1994.205.12.1722","article-title":"Prognostic factors for treatment of malignant lymphoma in dogs","volume":"205","author":"Teske","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304371686700_jvim12302-bib-0027","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1476-5829.2011.00317.x","article-title":"Clinical, histopathological, and immunohistochemical characterization of canine indolent lymphoma","volume":"11(4)","author":"Flood-Knapik","year":"2013","journal-title":"Vet Comp Oncol"},{"key":"2026020304371686700_jvim12302-bib-0028","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1476-5829.2010.00230.x","article-title":"CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma","volume":"9","author":"Rebhun","year":"2010","journal-title":"Vet Comp Oncol"},{"key":"2026020304371686700_jvim12302-bib-0029","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ajh.20707","article-title":"Cryopreservation of hematopoietic stem cells","volume":"82","author":"Berz","year":"2007","journal-title":"Am J Hematol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12302","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/28\/2\/529\/66686067\/jvim12302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/28\/2\/529\/66686067\/jvim12302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:37:48Z","timestamp":1770111468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/28\/2\/529\/8452155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.12302","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,3]]},"published":{"date-parts":[[2014,3,1]]}}}